5th Annual Formulation & Forced Degradation
Main Conference: Day One
| 7:45 | Conference Registration and Morning Coffee |
| 8:30 |
Chairperson's Opening Remarks David Lechuga-Ballesteros, PhD, Senior Director R&D, ARIDIS PHARMACEUTICALS Dr. Ian C. Boulton, Former Development Scientist, Formulation & Stability, SANOFI-PASTEUR, President and Chief Scientific Officer, THE IMAGO GROUP |
| 8:45 |
Case Study: Application of Ultrasonic Rheometry to Study Protein Rheology at High Protein Concentrations Devendra (Davy) S. Kalonia, PhD, Associate Professor, UNIVERSITY OF CONNECTICUT |
| 9:15 |
Relating Protein-Osmolyte Interactions to Protein Stability David Wayne Bolen, PhD, Professor of Biochemistry & Molecular Biology, UNIVERSITY OF TEXAS MEDICAL BRANCH |
| 9:45 |
Case Study: Investigate and Characterize Antibody Fragments and Aggregates Using Biophysical Methods to Support Formulation Development Qin "Chin" Zou, PhD, Research Scientist, ELI LILLY AND CO. |
| 10:15 | 30 Minute Networking & Refreshment Break |
| 10:45 |
Keynote Presentation- Report to Grand Ballroom
Guy Kawasaki, Former Apple Fellow,Managing Director, GARAGE TECHNOLOGY VENTURES & BEST SELLING AUTHOR |
| 11:45 | 5 Minute Transition Time |
| 11:50 |
Case Study: Tap Into the Strategy of Protein-Based Vaccine Formulation Development and Forced Degradation Mechanisms Li Shi, PhD, Associate Director, Pharmaceutical Research & Development, MERCK & COMPANY |
| 12:30 | Networking Lunch, Exhibit Hall Open, Book Signing |
| 1:45 |
Afternoon Tracks Begin
|
|
Track A: |
Track B: Analytical Track |
Track C: |
|
| 1:45 |
Case Study: Formulation for Lyophilized Proteins: Fast Dynamics as an Indicator of Protein Stability in Glass Marcus T. Cicerone, Polymers Division, NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY | Case Study: Phototstability of a Monoclonal Antibody
Melissa Perkins, PhD, Director of Drug Product Development, Pharmaceutical Sciences, HUMAN GENOME SCIENCES, INC. |
The 2008 Technology Landscape: Uncover Emerging Advancements in Drug Delivery to Map Out Future Product Development Opportunities for Your Programs Bill Lampert, PhD, Senior Vice President Pharmaceutical Development, PACIRA PHARMACEUTICALS Christof Boehler, CEO, PANTEC BIOSOLUTIONS |
| 2:30 |
Control of Unique Variants of a Monoclonal Antibody Through Formulation Development R. Kendall Kessler, PhD, Principal Scientist, Pharmaceutical R&D, PFIZER | Case Study: Detection and Quantitation of Oxidation in Monoclonal Antibodies
Jianming Mo, PhD, PFIZER |
AdvaTab® – Development of Novel Orally Disintegrating Tablet Products Troy Harmon, Vice President, Business Development, EURAND |
| 3:00 |
Case Studies: Explore the Potential for Determining Leachables Using HPLC Multi-Detection Systems James F. Castner, PhD, Senior Principal Research Scientist, BRISTOL MYERS SQUIBB- MEDICAL IMAGING | Case Studies: Deamidation in Protein Drug Formulations
Elizabeth M. Topp, PhD, Professor, Department of Pharmaceutical Chemistry, THE UNIVERSITY OF KANSAS |
Nanotechnology - The Small Technology with Huge Potential Gary Liversidege, PhD, Senior Director, Commercial Development, ELAN DRUG TECHNOLOGIES |
| 3:45 | 30 Minute Networking & Refreshment Break | ||
| 4:15 | Case Study: Fundamental Considerations in Frozen Drug Substance for Product Development
Sandeep Nema, PhD, Executive Director of Research & Development, PFIZER | Case Study: Laboratory Models for Induction of Protein Degradation /Aggregation: Evaluating Processing Steps in Manufacturing Don Eisenhauer, PhD, Research Investigator, ABBOTT LABORATORIES |
Best Practices in Driving Patient-Friendly Products: Bringing the Consumer Voice to Product Development TBD, Manager, Business Development, 3M DRUG DELIVERY SYSTEMS |
| 5:00 |
Day One Concludes; Exhibit Hall Open |
||
Bottom menu
Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved